DOCK 3 TUMOR SUPPRESSOR GENE

Details for Australian Patent Application No. 2002310393 (hide)

Owner THE GENERAL HOSPITAL CORPORATION

Inventors YAJNIK, Vijay; PAULDING, Charles; MCCLATCHEY, Andrea; HABER, Daniel

Pub. Number AU-A-2002310393

PCT Number PCT/US02/18507

PCT Pub. Number WO2002/100876

Priority 60/297,382 11.06.01 US

Filing date 10 June 2002

Wipo publication date 23 December 2002

International Classifications

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 015/00 Mutation or genetic engineering

C12P 021/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12P 021/04 Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/297,382 11.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002310393

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002310394-Ink jet ink compositions containing fluorochemical surfactants

2002310392-LINEAR VALVE ACTUATOR